Chief Scientific Officer
Halozyme Therapeutics
Chris Wahl, MD, MBA is the Chief Scientific Officer of Halozyme Therapeutics. Dr. Wahl has over 20 years of experience in the pharmaceutical and biotech industries and over 10 years of experience developing drug delivery technologies and associated therapeutics. He has worked across large and small molecules, novel formulations, devices and drug device combination products. He is also an inventor with more than 150 U.S. and international patents and patent applications.